SUPPLEMENTAL FIGURES.docx (398.89 kB)
Download file

Supplementary Figures – A real-world US study of recurrence risks using combined clinicopathological features in HR-positive, HER2-negative early breast cancer

Download (398.89 kB)
figure
posted on 25.05.2022, 08:48 by Figshare Future Science GroupFigshare Future Science Group, Kristin M Sheffield, Jessica R Peachey, Michael Method, Brenda R Grimes, Jacqueline Brown, Kim Saverno, Tomoko Sugihara, Zhanglin Lin Cui, Kimberley T Lee

  

Figure S1. Study Cohort Attrition

  

Figure S2. Kaplan-Meier Curves of IDFS (A) and DRFS (B) for the High-risk Group Compared with the Non-high-risk Group with 1-3 Positive Lymph Nodes

  

Figure S3. Kaplan-Meier Curves of Invasive Disease-free Survival (A) and Distant Relapse-free Survival (B) for the High-risk Subgroup that Matches the US Indication Compared with the Non-high-risk Group

Funding

Eli Lilly and Company, IN, USA

History